Sumitomo Pharma America, Inc.
Clinical trials sponsored by Sumitomo Pharma America, Inc., explained in plain language.
-
New hope for advanced cancers: experimental drug SMP-3124LP enters human trials
Disease control Recruiting nowThis study tests an experimental drug called SMP-3124LP in adults with advanced solid tumors that have not responded to standard treatments. The goal is to find a safe dose and see if the drug can shrink tumors. About 120 participants will take part in two phases: first to check …
Phase: PHASE1, PHASE2 • Sponsor: Sumitomo Pharma America, Inc. • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
New pill shows promise for rare bone marrow cancer
Disease control Recruiting nowThis study tests an oral drug called nuvisertib for people with myelofibrosis, a rare bone marrow disorder. The goal is to see if it can safely shrink an enlarged spleen and improve symptoms. About 240 adults with intermediate or high-risk disease who have not responded well to o…
Phase: PHASE1, PHASE2 • Sponsor: Sumitomo Pharma America, Inc. • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC
-
New hope for leukemia: experimental drug enzomenib enters human trials
Disease control Recruiting nowThis study tests an experimental drug called enzomenib in about 600 people with acute leukemia and certain other blood cancers. The goal is to find the safest dose and see if the drug can shrink or control the cancer. Participants must have cancers that came back or did not respo…
Phase: PHASE1, PHASE2 • Sponsor: Sumitomo Pharma America, Inc. • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC